Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -84,936 | -38,253 | -31,209 | -16,002 | -84,234 |
| Depreciation Amortization | 4,464 | 3,268 | 2,184 | 1,085 | 5,601 |
| Accounts receivable | -3,000 | N/A | N/A | N/A | N/A |
| Other Working Capital | -18,263 | 907 | -693 | -743 | 1,634 |
| Other Operating Activity | 36,070 | -1,330 | 4,644 | 2,075 | 41,980 |
| Operating Cash Flow | $-65,665 | $-35,408 | $-25,074 | $-13,585 | $-35,019 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 70,213 | 58,966 | 31,801 | 9,820 | -82,378 |
| PPE Investments | -4,151 | -903 | -501 | -444 | -1,336 |
| Investing Cash Flow | $66,062 | $58,063 | $31,300 | $9,376 | $-83,714 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 1,758 |
| Common Stock Issued | 24,861 | 8,530 | 8,357 | 5,878 | 178 |
| Financing Cash Flow | $24,861 | $8,530 | $8,357 | $5,878 | $1,936 |
| Beginning Cash Position | 13,571 | 13,571 | 13,571 | 13,571 | 130,368 |
| End Cash Position | 38,829 | 44,756 | 28,154 | 15,240 | 13,571 |
| Net Cash Flow | $25,258 | $31,185 | $14,583 | $1,669 | $-116,797 |
| Free Cash Flow | |||||
| Operating Cash Flow | -65,665 | -35,408 | -25,074 | -13,585 | -35,019 |
| Capital Expenditure | -4,151 | -903 | -501 | -444 | -1,336 |
| Free Cash Flow | -69,816 | -36,311 | -25,575 | -14,029 | -36,355 |